Clearmind Medicine files European patent application for PTSD compounds May 5, 2026 08:53AM
Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of PTSD May 5, 2026 08:50AM
Clearmind Medicine responds to Trump executive order on psychedelic drugs Apr 20, 2026 04:03PM
Clearmind Medicine Welcomes President Trump’s Executive Order as a Historic Catalyst for Psychedelic Innovation and Veteran Mental Health Care Apr 20, 2026 04:03PM